Amicus Therapeutics Inc (NASDAQ:FOLD)

During the Trading Day
5.82 -0.12 / -2.02%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
5.82 +0.0041 / +0.07%
Volume: 4.7K
Health Technology

Company Description

Amicus Therapeutics, Inc. is a biopharmaceutical company focuses on the discovery, development and commercialization of orally administered, small molecule drugs known as pharmacological chaperones for the treatment of rare diseases, pharmacological chaperones are a novel, first-in-class approach to treating a broad range of diseases, including lysosomal storage disorders and diseases of neurodegeneration. Amicus develops pharmacological chaperones oral therapies that bind to and stabilize the affected proteins, restoring their shape, proper trafficking, and biological activity. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ.

Contact Information

Amicus Therapeutics, Inc.
1 Cedar Brook Drive
Cranbury New Jersey 08512
P:(609) 662-2000
Investor Relations:
(609) 662-5044



Mutual fund holders7.93%
Individual stakeholders54.56%
Other institutional34.92%

Top Executives

John F. CrowleyChairman, President & Chief Executive Officer
Bradley L. CampbellChief Operating Officer
William D. BairdChief Financial Officer
Enrique DiloneVice President-Technical Operations
Robert E. WinklerVice President-Clinical Research & Operations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.